David R. Hillyard, MD | ARUP Laboratories

David R. Hillyard, MD

David R. Hillyard, MD

Medical Director: Molecular Infectious Diseases

Professor, University of Utah School of Medicine

Specialties

Medical microbiology
Microbial genetics

Education

Medical Degree—Columbia University
Residency—Pathology Chief Resident, St. Luke’s—Roosevelt Hospital
Fellowship—Microbial Genetics, University of Utah School of Medicine
Fellowship—Medical Microbiology, University of Utah School of Medicine

Certification/Affiliations

New York Qualification

Research Interests

Molecular Pathology and Genetics
Hepatitis, HIV

Awards

National Science Foundation Scholarship (Genetics)

Recent Publications

Tolan NV, et al. New therapies for treating hepatitis C virus: impact on laboratory testing recommendations and clinical management. Clin Chem. 2017 Dec;63(12):1799–1805.
Pyne MT, et al. Sequencing of the hepatitis D virus RNA WHO international standard. J Clin Virol. 2017 May;90:52–6.
Hayden RT, et al. Progress in Quantitative Viral Load Testing: Variability and Impact of the WHO Quantitative International Standards. J Clin Microbiol. 2017 Feb;55(2):423–30.
Zhang Y, et al. Serology enhances molecular diagnosis of respiratory virus infections other than influenza in children and adults hospitalized with community-acquired pneumonia. J Clin Microbiol. 2016 Dec 28;55(1):79–89.
Fryer JF, et al. A collaborative study to establish the 1st WHO International Standard of human cytomegalovirus for nucleic acid amplification technology. Biological. 2016 Jul;44(4):242–51.
Mallory MA, et al. Evaluation of the Abbott Realtime HCV genotype plus RUO (PLUS) assay with reference to core and NS5B sequencing. J Clin Virol. 2017 May;90:26–31.
Pyne MT, Mallory M, Hillyard DR. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test. J Clin Virol. 2015 Apr;65:54–7.
Jain S, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015 Feb 26;372(9):835–45.
Pyne MT, et al. Testing and genotyping of high-risk human papillomavirus by the cobas HPV test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samples. J Clin Microbiol. 2014 May;52(5):1720–3.
Mallory MA, et al. Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing. J Clin Virol. 2014 May;60(1):22–6.